Annual CFF
$22.16 M
-$331.00 K-1.47%
31 December 2023
Summary:
NKGen Biotech Common Stock annual cash flow from financing activities is currently $22.16 million, with the most recent change of -$331.00 thousand (-1.47%) on 31 December 2023. NKGN annual CFF is now -1.47% below its all-time high of $22.49 million, reached on 31 December 2022.NKGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$6.06 M
+$2.05 M+51.21%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly cash flow from financing activities is currently $6.06 million, with the most recent change of +$2.05 million (+51.21%) on 30 June 2024. Over the past year, it has dropped by -$6.07 million (-50.05%). NKGN quarterly CFF is now -64.33% below its all-time high of $16.98 million, reached on 01 September 2022.NKGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$20.39 M
-$212.00 K-1.03%
30 June 2024
Summary:
NKGen Biotech Common Stock TTM cash flow from financing activities is currently $20.39 million, with the most recent change of -$212.00 thousand (-1.03%) on 30 June 2024. Over the past year, it has dropped by -$3.57 million (-14.88%). NKGN TTM CFF is now -29.23% below its all-time high of $28.81 million, reached on 30 June 2023.NKGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | -50.0% | -14.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NKGN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.5% | +9.9% | -64.3% | +436.1% | -29.2% | +20.1% |
| 5 y | 5 years | -1.5% | +9.9% | -64.3% | +436.1% | -29.2% | +20.1% |
| alltime | all time | -1.5% | +9.9% | -64.3% | +436.1% | -29.2% | +20.1% |
NKGen Biotech Common Stock Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $6.06 M(+51.2%) | $20.39 M(-1.0%) |
| Mar 2024 | - | $4.01 M(-322.2%) | $20.60 M(-7.0%) |
| Dec 2023 | $22.16 M | -$1.80 M(-114.9%) | $22.16 M(-7.5%) |
| Sept 2023 | - | $12.13 M(+93.4%) | $23.96 M(-16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $6.27 M(+12.8%) | $28.81 M(+27.8%) |
| Mar 2023 | - | $5.56 M(-67.3%) | $22.54 M(+32.7%) |
| Dec 2022 | $22.49 M(+11.5%) | - | - |
| Sept 2022 | - | $16.98 M | $16.98 M |
| Dec 2021 | $20.16 M | - | - |
FAQ
- What is NKGen Biotech Common Stock annual cash flow from financing activities?
- What is the all time high annual CFF for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual CFF year-on-year change?
- What is NKGen Biotech Common Stock quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly CFF year-on-year change?
- What is NKGen Biotech Common Stock TTM cash flow from financing activities?
- What is the all time high TTM CFF for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock TTM CFF year-on-year change?
What is NKGen Biotech Common Stock annual cash flow from financing activities?
The current annual CFF of NKGN is $22.16 M
What is the all time high annual CFF for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual cash flow from financing activities is $22.49 M
What is NKGen Biotech Common Stock annual CFF year-on-year change?
Over the past year, NKGN annual cash flow from financing activities has changed by -$331.00 K (-1.47%)
What is NKGen Biotech Common Stock quarterly cash flow from financing activities?
The current quarterly CFF of NKGN is $6.06 M
What is the all time high quarterly CFF for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly cash flow from financing activities is $16.98 M
What is NKGen Biotech Common Stock quarterly CFF year-on-year change?
Over the past year, NKGN quarterly cash flow from financing activities has changed by -$6.07 M (-50.05%)
What is NKGen Biotech Common Stock TTM cash flow from financing activities?
The current TTM CFF of NKGN is $20.39 M
What is the all time high TTM CFF for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high TTM cash flow from financing activities is $28.81 M
What is NKGen Biotech Common Stock TTM CFF year-on-year change?
Over the past year, NKGN TTM cash flow from financing activities has changed by -$3.57 M (-14.88%)